Home > Insider Trading > Filing (0000899243-16-015093)

Filing Details

Accession Number:: 0000899243-16-015093
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2016-03-02 21:03:01
Reporting Period:: 2016-03-01

Filing Date:: 2016-03-02
Accepted Time:: 2016-03-02 21:03:01
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1594864	Juno Therapeutics Inc.	JUNO	Biological Products, (No Disgnostic Substances) (2836)	463656275

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1627387	Steve Harr	C/O 307 Westlake Avenue North, Suite 300 Seattle WA 98109	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Disposition	2016-03-01	2,013	$35.06	762,987	No	4	S	Direct
Common Stock	Disposition	2016-03-01	10,581	$36.20	752,406	No	4	S	Direct
Common Stock	Disposition	2016-03-01	900	$36.82	751,506	No	4	S	Direct
Common Stock	Disposition	2016-03-01	6,387	$38.18	745,119	No	4	S	Direct
Common Stock	Disposition	2016-03-01	10,076	$39.21	735,043	No	4	S	Direct
Common Stock	Disposition	2016-03-01	43	$39.88	735,000	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Footnotes

This transaction was executed in multiple trades at prices ranging from $34.55 to $35.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $35.56 to $36.54. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $36.57 to $37.35. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $37.58 to $38.57. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
This transaction was executed in multiple trades at prices ranging from $38.5862 to $39.58. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 23, 2014, as amended March 24, 2015.